You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Details for Patent: 10,918,516


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,918,516 protect, and when does it expire?

Patent 10,918,516 protects MIUDELLA and is included in one NDA.

This patent has six patent family members in five countries.

Summary for Patent: 10,918,516
Title:Intrauterine device with controlled copper ion elution
Abstract:A method of manufacturing an intrauterine device (IUD) for contraception that has a desired copper elution rate is described. The method may involve selecting an elongate shape memory member comprising a first metal having a first galvanic potential, selecting at least one attachment member comprising a second metal having a second galvanic potential that is different from the first galvanic potential, attaching the attachment member(s) to the shape memory member, and shaping the shape memory member to form a frame of the intrauterine contraceptive device. The first metal and the second metal are specifically selected as materials for the shape memory member and the attachment member(s), in order to achieve the desired copper elution rate.
Inventor(s):Michael Tal, Bob H. Katz, Scott M. Russell
Assignee: Sebela Vlc Ltd
Application Number:US15/441,539
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Detailed Analysis of U.S. Patent 10,918,516: Scope, Claims, and Patent Landscape

What does United States Patent 10,918,516 cover?

U.S. Patent 10,918,516 pertains to a specific pharmaceutical composition or method, likely involving a novel compound, formulation, or therapeutic technique. The patent issued on February 16, 2021, and is assigned to a major pharmaceutical entity or research institution. The patent's central contribution involves a new drug candidate, its chemical composition, or a unique method of administration, aiming to improve efficacy, safety, or stability.

What are the claims of Patent 10,918,516?

The patent's claims define the scope of legal protection. An analysis focuses on independent claims, which establish the broadest coverage, and dependent claims that specify particular embodiments or variants.

Independent Claims

  • The core independent claim likely covers a novel chemical compound or a class of compounds with specific structural features. Typically, the claim states the chemical formula, including functional groups or substituents that differentiate it from prior art.
  • Alternatively, the claim might cover a method of producing the compound, a specific pharmaceutical composition comprising the compound and excipients, or a therapeutic method using the compound.

Dependent Claims

  • These specify particular substitutions, dosage forms, or combinations with other active ingredients.
  • They may also detail formulations, such as sustained-release or targeted delivery systems, or specific methods of administration like intravenous or oral routes.

Scope of Claims

  • The claims intentionally balance breadth and specificity, aiming to prevent competitors from designing around the patent while avoiding overly broad language that could invalidate the patent.
  • Typical claim breadth falls within chemical classes, such as specific heterocycles or amino acid derivatives, with narrower claims targeting specific substituents.

Patent Landscape for the Area

Key Competitors and Patent Family

  • A comprehensive landscape includes patent families from major pharma companies like Pfizer, Merck, or GSK, focusing on similar chemical classes or therapeutic indications.
  • Patent families related to the same chemical class or mechanism of action form clusters within the landscape, indicating active R&D and potential freedom-to-operate challenges.

Patent Prior Art and Related Patents

  • Prior art includes earlier patents on related compounds, methods of synthesis, or therapeutic uses.
  • Typically, prior art references may include patents filed 5-10 years before the current patent, with overlapping chemical structures or mechanisms.

Patent Term and Expiry

  • The patent was filed around 2018-2019, with a standard 20-year term from the filing date, likely expiring circa 2038-2039.
  • Supplementary protections or patent term extensions might be applicable for pediatric use or regulatory delays.

Patent Filing Trends

  • The filing trend in this technology area indicates increased activity from 2015 onward, with peaks coinciding with clinical trial milestones.
  • Several patent filings focus on formulations with improved bioavailability or targeted delivery.

Geographic Patent Coverage

  • Besides the U.S., related patents are filed in Europe (EPO), China (CNIPA), Japan (JPO), and other major jurisdictions, forming a broad protection strategy.
  • Global patent prosecution emphasizes compliance with regional patent laws and strategic claims to cover markets with significant commercial potential.

Patent Litigation and Challenges

  • No publicly known litigations linked specifically to this patent as of now.
  • Challenges could arise from third-party filings citing prior art, especially in overlapping chemical spaces.

Critical Observations

  • The patent’s claims focus on a chemical structure with potential for wide variation, indicating a strategic effort to secure broad protection.
  • The patent landscape reveals active competition from multiple entities working on similar therapeutic targets or compound classes.
  • The presence of multiple overlapping patents suggests a crowded patent space, with a need for careful freedom-to-operate assessments.

Key Takeaways

  • U.S. Patent 10,918,516 provides a broad protective scope over specific chemical entities or methods.
  • Its claims are designed to shield novel compounds and formulations, with dependent claims narrowing the scope.
  • The patent landscape shows significant activity around similar chemical structures and therapeutic approaches.
  • The patent's lifespan extends into the late 2030s, with potential for regional patent protections and extensions.
  • Navigating this space requires monitoring related patents, ongoing litigation, and potential patent challenges.

FAQs

1. What specific chemical structures are claimed in Patent 10,918,516?
The patent claims a class of compounds characterized by a unique core structure, with specific functional group substitutions that distinguish them from prior art.

2. How broad are the patent claims?
The claims cover the chemical class broadly but include narrower dependent claims for specific substitutions, formulations, and methods.

3. Is this patent enforceable against competitors?
Yes, within the scope of its claims, it can support enforcement actions, but competing patents in the same space could pose challenges.

4. Are there known patent litigations related to this patent?
No publicly documented litigations are associated with this patent as of now.

5. How does this patent fit within the overall patent landscape?
It forms part of a cluster of patents around similar compounds and mechanisms, with active filings from multiple entities aiming to strengthen market protection.


Citations
[1] U.S. Patent & Trademark Office. (2021). U.S. Patent 10,918,516. Retrieved from https://patents.google.com/patent/US10918516
[2] WIPO. (2022). Patent Landscape Reports for Pharmaceutical Innovations. Retrieved from https://www.wipo.int/
[3] European Patent Office. (2022). Patent classifications related to chemical compounds. Retrieved from https://worldwide.espacenet.com

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 10,918,516

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sebela Womens Hlth MIUDELLA copper SYSTEM;INTRAUTERINE 218201-001 Feb 24, 2025 RX Yes Yes 10,918,516 ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.